Business Description
Renalytix is a London-based medical diagnostics company founded in 2018, operating across the United Kingdom and the United States. Its flagship product, KidneyIntelX, analyzes blood samples, genetic data, and patient health records to produce a personalized risk score that helps doctors identify and manage kidney disease more effectively. The company works with Mount Sinai Health System under a licensing agreement and also supports pharmaceutical research by helping identify suitable patients for clinical trials and potential drug targets.
